Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes

Vaccine

Volumn 19, Issue 4-5, 2000, Pages 498-507

  Woollard, David J ^a   Gauci, Charles G ^a   Heath, David D ^b   Lightowlers, Marshall W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AGRESEARCH   (New Zealand)

Author keywords

Echinococcus granulosus; Epitope; Vaccine

Indexed keywords

COMPLEMENT FIXING ANTIBODY; EPITOPE; RECOMBINANT VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN ANTIBODY REACTION; ARTICLE; CONFORMATION; CONTROLLED STUDY; ECHINOCOCCOSIS; ECHINOCOCCUS GRANULOSUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE MAPPING; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PEPTIDE MAPPING; PRIORITY JOURNAL; SHEEP; VACCINATION;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BASE SEQUENCE; DNA PRIMERS; ECHINOCOCCOSIS; ECHINOCOCCUS; EPITOPE MAPPING; EPITOPES; HELMINTH PROTEINS; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; SHEEP; SHEEP DISEASES; SUPPORT, NON-U.S. GOV'T; VACCINES, SYNTHETIC;

EID: 0034668210     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00192-4     Document Type: Article

References (35)

1. Lightowlers M.W., Lawrence S.B., Gauci C.G., Young J., Ralston M., Maas D., Heath D.D. Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol. 18:1996;457-462.
2. Woollard D.J., Gauci C.G., Heath D.D., Lightowlers M.W. Epitope specificities and antibody responses to the EG95 hydatid vaccine. Parasite Immunol. 20:1998;535-540.
3. Woollard DJ, Heath DD, Lightowlers MW, Assessment of protective immune responses against hydatid disease in sheep by immunisation with synthetic peptide antigens. Parasitology, in press.
4. Heath D.D., Lawrence S.B. Antigenic polypeptides of Echinococcus granulosus oncospheres and definition of protective molecules. Parasite Immunol. 18:1996;347-357.
5. Dempster R.P., Harrison G.B., Berridge M.V., Heath D.D. Echinococcus granulosus: use of an intermediate host mouse model to evaluate sources of protective antigens and a role for antibody in the immune response. Int. J. Parasitol. 22:1992;435-441.
6. Smith D.B., Johnson K.S. Single step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene. 67:1988;31-40.
7. Cartwright G.A., Rothel J.S., Lightowlers M.W. Conventional immunoassays underestimate anti-GST antibody titre. J. Immunol. Methods. 179:1995;31-35.
8. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning. A laboratory manual. 1989;Cold Spring Harbour Laboratory Press, Cold Spring Harbour, USA.
9. Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
10. Heath D.D., Lawrence S.B. Echinococcus granulosus: development in vitro from oncosphere to immature hydatid cyst. Parasitology. 73:1976;417-423.
11. Lightowlers M.W., Jensen O., Fernandez E., Iriarte J.A., Woollard D.J., Gauci C.G., Jenkins D.J., Heath D.D. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep. Int. J. Parasitol. 29:1999;531-534.
12. 2. Vet. Immunol. Immunopathol. 14:1987;187-196.
13. Bos E.S., van der Doelen A.A., van Rooy N. Schuurs AHWM. 3,3′,5,5′-tetramethylbenzidine as an Ames-test negative chromogen for horse-radish peroxidase in enzyme immunoassay. J. Immunoassay. 2:1981;187-204.
14. Dale J.B., Beachey E.H. Localization of protective epitopes of the amino terminus of type 5 streptococcal M protein. J. Exp. Med. 163:1986;1191-1202.
15. Schmidt M.A., O'Hanley P., Lark D., Schoolnik G.K. Synthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model. Proc. Natl. Acad. Sci. USA. 85:1988;1247-1251.
16. Beachey E.H., Seyer J.M. Protective and nonprotective epitopes of chemically synthesized peptides of the NH2-terminal region of type 6 streptococcal M protein. J. Immunol. 136:1986;2287-2292.
17. Grosfeld H., Velan B., Leitner M., Lustig S., Lachi B.E., Cohen S., Shafferman A. Delineation of protective epitopes on the E2-envelope glycoprotein of Semliki Forest virus. Vaccine. 9:1991;451-456.
18. Weber K., Kuter D.J. Reversible denaturation of enzymes by sodium dodecyl sulfate. J. Biol. Chem. 246:1971;4504-4509.
19. Green N., Alexander H., Olson A., Alexander S., Shinnick T.M., Sutcliffe J.G., Lerner R.A. Immunogenic structure of the influenza virus hemagglutinin. Cell. 28:1982;477-487.
20. Dorow D.S., Shi P.T., Carbone F.R., Minasian E., Todd P.E., Leach S.J. Two large immunogenic and antigenic myoglobin peptides and the effects of cyclisation. Mol. Immunol. 22:1985;1255-1264.
21. Maurer P.H., Callahan H.J. Proteins and polypeptides as antigens. Methods Enzymol. 70:1980;49-70.
22. Richman S.J., Vedvick T.S., Reese R.T. Peptide mapping of conformational epitopes in a human malarial parasite heat shock protein. J. Immunol. 143:1989;285-292.
23. Jemmerson R. Antigenicity and native structure of globular proteins: low frequency of peptide reactive antibodies. Proc. Natl. Acad. Sci. USA. 84:1987;9180-9184.
24. Lightowlers M.W., Flisser A., Gauci C.G., Heath D.D., Jensen O., Rolfe R. Vaccination against cysticercosis and hydatid disease. Parasitol. Today. 16:2000;191-196.
25. Waterkeyn J., Gauci C., Cowman A., Lightowlers M. Sequence analysis of a gene family encoding Taenia ovis vaccine antigens expressed during embryogenesis of eggs. Mol. Biochem. Parasitol. 86:1997;75-84.
26. Bork P., Doolittle R.F. Proposed acquisition of an animal protein domain by bacteria. Proc. Natl. Acad. Sci. USA. 89:1992;8990-8994.
27. Bork P., Holm L., Sander C. The immunoglobulin fold. Structural classification, sequence patterns and common core. J. Mol. Biol. 242:1994;309-320.
28. Campbell I.D., Spitzfaden C. Building proteins with fibronectin type III modules. Structure. 2:1994;333-337.
29. Main A.L., Harvey T.S., Baron M., Boyd J., Campbell I.D. The three-dimensional structure of the tenth type III module of fibronectin: an insight into RGD-mediated interactions. Cell. 71:1992;671-678.
30. Bork P., Doolittle R.F. Fibronectin type III modules in the receptor phosphatase CD45 and tapeworm antigens. Protein Sci. 2:1993;1185-1187.
31. Potts J.R., Campbell I.D. Structure and function of fibronectin modules. Matrix Biol. 15:1996;313-320.
32. Steward M.W., Howard C.R. The potential of synthetic peptides for vaccines. Med. Lab. Sci. 42:1985;376-387.
33. Milich D.R. Synthetic peptides: prospects for vaccine development. Semin. Immunol. 2:1990;307-315.
34. Brown F.J. The potential of peptides as vaccines. Sem. Virology. 1:1990;67-74.
35. Jefferies D. Selection of novel ligands from phage display libraries: an alternative approach to drug and vaccine discovery? Parasitol. Today. 14:1998;202-206.